BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis1

299. Cystic fibrosis


Clinical trials : 1,695 Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2009-012575-10-IT
(EUCTR)
18/01/2022Trial of Therapy for the first pulmonary infection by Pseudomonas aeruginosa in Cystic Fibrosis.Trial of Optimal Therapy for Pseudomonas Eradication in Cystic Fibrosis - TORPEDO-FC First Pseudomonas aeruginosa infection in patients with cystic fibrosis
MedDRA version: 20.0;Level: LLT;Classification code 10021860;Term: Infection Pseudomonas aeruginosa;System Organ Class: 100000004862;Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
Trade Name: TOTTIZIM - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 10 ML
INN or Proposed INN: CEFTAZIDIMA PENTAIDRATO
Other descriptive name: ceftazidime
Trade Name: BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML
Product Name: Tobramicina
Product Code: tobramicina
INN or Proposed INN: TOBRAMICINA SOLFATO
Other descriptive name: Tobramicyn
Trade Name: CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE
Product Name: Ciprofloxacina
INN or Proposed INN: CIPROFLOXACINA CLORIDRATO
Other descriptive name: ciprofloxacin
UNIVERSITY OF LIVERPOOLNULLNAFemale: yes
Male: yes
286Phase 4United Kingdom;Italy;Sweden